Biotech entity
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Health Care Select Sector Index, the most common co-covered peer. We currently track 1 Biotech story that mention Invesco, all published on August 2, 2026.
Last mentioned: Aug 2, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Health Care Select Sector Index, the most common co-covered peer. We currently track 1 Biotech story that mention Invesco, all published on August 2, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Invesco. Shared-story counts are live from our verified record — not editorial picks.
Biotechnology investors face a critical choice: the concentrated growth of IBBQ, up 45.5% in the past year, or the safer, diversified XLV. This analysis delves into the binary event risk and regulatory catalysts shaping IBBQ's trajectory.
Source: Andy Gould (us) · finance.yahoo.com
Invesco is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
